Journal of Cancer Research and Therapeutics Close
 

Table 3: Comparison of integral dose for target (high-risk clinical target volume) and organs at risk (bladder, rectum, and sigmoid colon) between Iridium-192 and Cobalt-60 plans

Table 3: Comparison of integral dose for target (high-risk clinical target volume) and organs at risk (bladder, rectum, and sigmoid colon) between Iridium-192 and Cobalt-60 plans